CPRX Short Volume

Catalyst Pharmaceuticals, Inc. (CPRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.81B, listed on NASDAQ, employing roughly 181 people, carrying a beta of 0.72 to the broader market. Catalyst Pharmaceuticals, Inc. Led by Richard John Daly, public since 2006-11-08.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
358.4K
Total Volume
730.4K
Short %
49.07%
30-Day Avg Short %
36.17%

Showing 30 days of FINRA short volume data for Catalyst Pharmaceuticals, Inc..

Learn how short volume is reported and how to read the data →

CPRX most-active contracts

TypeStrikeExpirationVolumeOIIVBidAsk
CALL$35.00Dec 18, 20264051.8K909.8%$0.05$0.15
CALL$30.00Dec 18, 20263256226.8%$1.60$1.70

Top 2 contracts from the ORATS-sourced nightly scan; ranked by volume within the broader S&P 500/400/600 + ETF universe.

Frequently asked CPRX short volume questions

What is the daily CPRX short volume?
As of May 15, 2026, Catalyst Pharmaceuticals, Inc. (CPRX) short volume is 358.4K shares against 730.4K total reported volume, or 49.07% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is CPRX short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does CPRX short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.